Harvey Investment Co. LLC Purchases 190 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Harvey Investment Co. LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 4,841 shares of the healthcare conglomerate’s stock after acquiring an additional 190 shares during the period. Harvey Investment Co. LLC’s holdings in UnitedHealth Group were worth $2,449,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in UNH. International Assets Investment Management LLC grew its position in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares during the last quarter. Accredited Investors Inc. boosted its position in UnitedHealth Group by 9,235.4% during the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after buying an additional 776,516 shares during the period. Raymond James & Associates raised its stake in shares of UnitedHealth Group by 33.1% during the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock valued at $1,380,661,000 after acquiring an additional 587,088 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec raised its position in UnitedHealth Group by 129.7% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after purchasing an additional 581,324 shares during the last quarter. Finally, State Street Corp increased its stake in shares of UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after buying an additional 563,554 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Down 1.9 %

Shares of UnitedHealth Group stock opened at $529.71 on Friday. The company’s 50 day moving average is $530.85 and its 200 day moving average is $564.52. The company has a market cap of $487.48 billion, a price-to-earnings ratio of 34.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the firm posted $5.83 earnings per share. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. TD Cowen upped their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Morgan Stanley decreased their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.